pillbase.ru

Kengrexal

Active substance: cangrelor

cangrelor

Centralised EU authorisationActive

Marketing holder: Chiesi Farmaceutici S.p.A.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • Cangrelor
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · CANGRELOR 50 mg/1
    68083-412
    Gland Pharma Limited
  • KENGREAL
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · CANGRELOR 50 mg/1
    10122-620
    Chiesi USA, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12090-9550-7bd5-963f-d1ec5ffded37,01a12093-3d74-7aae-8e52-619f1c6c5b1b;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/003773
Registration status
Active
ATC code
B01
Sources
  • product · EMA · EMEA/H/C/003773 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/003773 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/003773 · Verified 2026-10-09